These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2564723

  • 1. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR, Glassman HN, Estep CB, Maurath CJ, Jordan DC.
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
    Black HR, Chrysant SG, Curry CL, Frishman WH, Grimm RH, Lasseter KC, Okun R, Pool JL, Raizada V, Vlachakis ND.
    J Clin Pharmacol; 1992 Apr; 32(4):351-9. PubMed ID: 1349028
    [Abstract] [Full Text] [Related]

  • 3. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C, Beretta-Piccoli C, Weidmann P, Mordasini R.
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [Abstract] [Full Text] [Related]

  • 4. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 5. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Sep; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 6. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG.
    Am J Med; 1986 May 23; 80(5B):55-61. PubMed ID: 2872808
    [Abstract] [Full Text] [Related]

  • 7. Effect of terazosin on serum lipids.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):82-5. PubMed ID: 2872813
    [Abstract] [Full Text] [Related]

  • 8. Comparative trials of terazosin with other antihypertensive agents.
    Ruoff G.
    Am J Med; 1986 May 23; 80(5B):42-8. PubMed ID: 2872806
    [Abstract] [Full Text] [Related]

  • 9. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F.
    Am J Cardiol; 1987 May 29; 59(14):99G-104G. PubMed ID: 2884861
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun 29; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 12. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
    Saunders E.
    Am Heart J; 1991 Sep 29; 122(3 Pt 2):936-42. PubMed ID: 1678925
    [Abstract] [Full Text] [Related]

  • 13. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y.
    Am J Med; 1984 Feb 27; 76(2A):72-8. PubMed ID: 6142645
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):62-7. PubMed ID: 2872809
    [Abstract] [Full Text] [Related]

  • 15. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD.
    Am J Med; 1986 May 23; 80(5B):29-34. PubMed ID: 2872804
    [Abstract] [Full Text] [Related]

  • 16. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R, Angeli-Greaves M, Carvajal AR, Guerrero Pajuelo J, Armas Padilla MC, Armas-Hernández MJ.
    Am J Hypertens; 1996 May 23; 9(5):437-44. PubMed ID: 8735174
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
    Cohen JD.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):919-25. PubMed ID: 1678923
    [Abstract] [Full Text] [Related]

  • 18. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S, Monk JP.
    Drugs; 1987 May 23; 33(5):461-77. PubMed ID: 2885169
    [Abstract] [Full Text] [Related]

  • 19. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with essential hypertension.
    Lytle TB, Coles SJ, Waite MA.
    J Clin Pharm Ther; 1991 Aug 23; 16(4):263-73. PubMed ID: 1682328
    [Abstract] [Full Text] [Related]

  • 20. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ.
    Am J Med; 1989 Jan 23; 86(1B):8-13. PubMed ID: 2563311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.